Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial (Q38419469)

From Wikidata
Jump to navigation Jump to search
scientific article published on 06 December 2014
edit
Language Label Description Also known as
English
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial
scientific article published on 06 December 2014

    Statements

    Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial (English)
    Becky Schweighardt
    Troy Tompkins
    Kelly Lau
    Lynne Jesaitis
    Yulan Qi
    Donald G Musson
    Pamela Farmer
    Christine Haller
    Adam J Shaywitz
    Ke Yang
    Charles A O'Neill
    6 December 2014
    1012-1021.e6

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit